[P] Poster (5. Vaccine)

[P097] Clinically translatable intradermal delivery of a live attenuated Leishmania vaccine preserves efficacy

○FARZANEH VALANEZHAD^1,2,3, Jalal Alshaweesh^1,2, Shara Bakytbek^1,2,3, Alireza Valanezhad⁴, Kawsar Talaat⁵, Greg Matlashewski⁶, Sreenivas Gannavaram⁷, Hira Nakhasi⁷, Abhay Satoskar⁸, Shinjiro Hamano^1,2,3 (1. Department of Parasitology, Institute of Tropical Medicine (NEKKEN), The Joint Usage/Research Center on Tropical Disease, Nagasaki University, Nagasaki, Japan (Japan), 2. Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan (Japan), 3. The Vaccine Research and Development Center, DEJIMA Infectious Disease Research Alliance (DIDA), Nagasaki University, Nagasaki, Japan (Japan), 4. Department of Dental and Biomedical Materials Science, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan (Japan), 5. Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. (USA), 6. Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada (Canada), 7. Division of Emerging and Transfusion-Transmitted Diseases, CBER, FDA, Silver Spring, MD, 20993 US (USA), 8. Department of Pathology, The Ohio State University, Columbus, Ohio, US (USA))

閲覧にはパスワードが必要です